Literature DB >> 16265875

Obstacles and opportunities in the clinical development of targeted therapeutics.

Grace K Dy1, Alex A Adjei.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16265875     DOI: 10.1007/3-7643-7414-4_2

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


× No keyword cloud information.
  1 in total

1.  Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis.

Authors:  Xuefei Cao; Carmen Plasencia; Atsuko Kanzaki; Austin Yang; Terrence R Burke; Nouri Neamati
Journal:  Curr Cancer Drug Targets       Date:  2009-03       Impact factor: 3.428

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.